These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9141633

  • 1. Heregulin degradation in the absence of rapid receptor-mediated internalization.
    Baulida J, Carpenter G.
    Exp Cell Res; 1997 Apr 10; 232(1):167-72. PubMed ID: 9141633
    [Abstract] [Full Text] [Related]

  • 2. Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells.
    Li W, Park JW, Nuijens A, Sliwkowski MX, Keller GA.
    Oncogene; 1996 Jun 06; 12(11):2473-7. PubMed ID: 8649790
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1.
    Landgraf R, Pegram M, Slamon DJ, Eisenberg D.
    Biochemistry; 1998 Mar 03; 37(9):3220-8. PubMed ID: 9485477
    [Abstract] [Full Text] [Related]

  • 4. The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired.
    Sorkin A, Di Fiore PP, Carpenter G.
    Oncogene; 1993 Nov 03; 8(11):3021-8. PubMed ID: 8105439
    [Abstract] [Full Text] [Related]

  • 5. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired.
    Baulida J, Kraus MH, Alimandi M, Di Fiore PP, Carpenter G.
    J Biol Chem; 1996 Mar 01; 271(9):5251-7. PubMed ID: 8617810
    [Abstract] [Full Text] [Related]

  • 6. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
    Mincione G, Piccirelli A, Lazzereschi D, Salomon DS, Colletta G.
    J Cell Physiol; 1998 Aug 01; 176(2):383-91. PubMed ID: 9648926
    [Abstract] [Full Text] [Related]

  • 7. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX.
    Cancer Res; 1996 Mar 15; 56(6):1457-65. PubMed ID: 8640840
    [Abstract] [Full Text] [Related]

  • 8. Heregulin-dependent translocation and hyperphosphorylation of ErbB-2.
    Zhou W, Carpenter G.
    Oncogene; 2001 Jun 28; 20(29):3918-20. PubMed ID: 11439355
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
    Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA.
    Oncogene; 2000 Jul 20; 19(31):3460-9. PubMed ID: 10918604
    [Abstract] [Full Text] [Related]

  • 11. Signal transduction pathways induced by heregulin in MDA-MB-453 breast cancer cells.
    Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N, Lupu R.
    Oncogene; 1996 Apr 18; 12(8):1679-87. PubMed ID: 8622888
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 18; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 14. Heregulin activation of extracellular acidification in mammary carcinoma cells is associated with expression of HER2 and HER3.
    Chan SD, Antoniucci DM, Fok KS, Alajoki ML, Harkins RN, Thompson SA, Wada HG.
    J Biol Chem; 1995 Sep 22; 270(38):22608-13. PubMed ID: 7673253
    [Abstract] [Full Text] [Related]

  • 15. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM, Carpenter G.
    J Cell Physiol; 1993 Nov 22; 157(2):237-42. PubMed ID: 7901224
    [Abstract] [Full Text] [Related]

  • 16. The structural basis for the specificity of epidermal growth factor and heregulin binding.
    Barbacci EG, Guarino BC, Stroh JG, Singleton DH, Rosnack KJ, Moyer JD, Andrews GC.
    J Biol Chem; 1995 Apr 21; 270(16):9585-9. PubMed ID: 7721889
    [Abstract] [Full Text] [Related]

  • 17. Neuregulin-induced expression of the acetylcholine receptor requires endocytosis of ErbB receptors.
    Yang XL, Huang YZ, Xiong WC, Mei L.
    Mol Cell Neurosci; 2005 Feb 21; 28(2):335-46. PubMed ID: 15691714
    [Abstract] [Full Text] [Related]

  • 18. Human EGF receptor (HER) family and heregulin members are differentially expressed in epidermal keratinocytes and modulate differentiation.
    De Potter IY, Poumay Y, Squillace KA, Pittelkow MR.
    Exp Cell Res; 2001 Dec 10; 271(2):315-28. PubMed ID: 11716544
    [Abstract] [Full Text] [Related]

  • 19. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T, Toyoda H, Uchida D, Morimoto S.
    Oncogene; 1997 Dec 04; 15(23):2841-8. PubMed ID: 9419975
    [Abstract] [Full Text] [Related]

  • 20. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H, Riese DJ, Gilbert W, Stern DF, McMahan UJ.
    Nature; 1997 May 29; 387(6632):509-12. PubMed ID: 9168114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.